SKI Market

A+| A| A-|

Indian Indices

Sensex

75,318.39 117.54
( 0.16%)

Global Indices

Nasdaq

50,030.26 645.37
(1.31%)

Dow Jones

7,453.29 78.68
(1.07%)

Hang Seng

59,717.33 -833.26
(-1.38%)

Nikkei 225

10,425.97 95.42
(0.92%)

Forex

USD-INR

96.22 0.33
(0.34%)

EUR-INR

111.98 0.52
(0.46%)

GBP-INR

128.69 0.96
(0.75%)

JPY-INR

0.61 0.00
(0.28%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Lupin Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500257

INE326A01037

659.0710314

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

LUPIN

17.31

104400.67

EPS(TTM)

Face Value()

Div & Yield %

131.92

0.79

Back

Chandrima Mercantiles standalone net profit rises 2.50% in the December 2025 quarter

Feb 15,2026

Net profit of Chandrima Mercantiles rose 2.50% to Rs 0.41 crore in the quarter ended December 2025 as against Rs 0.40 crore during the previous quarter ended December 2024. Sales rose 93.60% to Rs 11.79 crore in the quarter ended December 2025 as against Rs 6.09 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	11.79	6.09	94
OPM %	1.44	6.57	-
PBDT	0.17	0.40	-58
PBT	0.17	0.40	-58
NP	0.41	0.40	3

75,318.39 117.54 ( 0.16%)

50,030.26 645.37 (1.31%)

7,453.29 78.68 (1.07%)

59,717.33 -833.26 (-1.38%)

10,425.97 95.42 (0.92%)

96.22 0.33 (0.34%)

111.98 0.52 (0.46%)

128.69 0.96 (0.75%)

0.61 0.00 (0.28%)